Literature DB >> 18495765

Herpes simplex virus type 1 ICP27 regulates expression of a variant, secreted form of glycoprotein C by an intron retention mechanism.

Lenka Sedlackova1, Keith D Perkins, Joy Lengyel, Anna K Strain, Vicky L van Santen, Stephen A Rice.   

Abstract

We previously showed that herpes simplex virus type 1 (HSV-1) immediate-early (IE) protein ICP27 can posttranscriptionally stimulate mRNA accumulation from a transfected viral late gene encoding glycoprotein C (gC) (K. D. Perkins, J. Gregonis, S. Borge, and S. A. Rice, J. Virol. 77:9872-9884, 2003). We began this study by asking whether ICP27 homologs from other herpesviruses can also mediate this activity. Although the homologs from varicella-zoster virus (VZV) and human cytomegalovirus (HCMV) were inactive, the homolog from bovine herpesvirus 4 (BHV-4), termed HORF1/2, was a very efficient transactivator. Surprisingly, most of the mRNA produced via HORF1/2 transactivation was 225 nucleotides shorter than expected due to the removal of a previously undescribed intron from the gC transcript. We found that the gC mRNA produced in the absence of transactivation was also mostly spliced. In contrast, gC mRNA produced by ICP27 transactivation was predominantly unspliced. Based on these results, we conclude that ICP27 has two distinct effects on the transfected gC gene: it (i) stimulates mRNA accumulation and (ii) promotes the retention of an intron. Interestingly, the spliced transcript encodes a variant of gC that lacks its transmembrane domain and is secreted from transfected cells. As the gC splicing signals are conserved among several HSV-1 strains, we investigated whether the variant gC is expressed during viral infection. We report here that both the spliced transcript and its encoded protein are readily detected in Vero cells infected with three different laboratory strains of wild-type HSV-1. Moreover, the variant gC is efficiently secreted from infected cells. We have designated this alternate form of the protein as gCsec. As the extracellular domain of gC is known to bind heparan sulfate-containing proteoglycans and to inhibit the complement cascade via an interaction with complement component C3b, we speculate that gCsec could function as a secreted virulence factor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18495765      PMCID: PMC2493323          DOI: 10.1128/JVI.00388-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  79 in total

1.  The HSV-1 UL45 gene product is not required for growth in Vero cells.

Authors:  R J Visalli; C R Brandt
Journal:  Virology       Date:  1991-11       Impact factor: 3.616

2.  Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity.

Authors:  B C Herold; D WuDunn; N Soltys; P G Spear
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

3.  The Epstein-Barr virus nuclear protein SM is both a post-transcriptional inhibitor and activator of gene expression.

Authors:  V Ruvolo; E Wang; S Boyle; S Swaminathan
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

4.  Genetic evidence for two distinct transactivation functions of the herpes simplex virus alpha protein ICP27.

Authors:  S A Rice; D M Knipe
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

5.  ICP27 mediates HSV RNA export by shuttling through a leucine-rich nuclear export signal and binding viral intronless RNAs through an RGG motif.

Authors:  R M Sandri-Goldin
Journal:  Genes Dev       Date:  1998-03-15       Impact factor: 11.361

6.  The herpes simplex virus immediate-early protein ICP27 shuttles between nucleus and cytoplasm.

Authors:  W E Mears; S A Rice
Journal:  Virology       Date:  1998-03-01       Impact factor: 3.616

7.  The open reading frame (ORF) 50a gene product regulates ORF 57 gene expression in herpesvirus saimiri.

Authors:  A Whitehouse; M Cooper; K T Hall; D M Meredith
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

8.  Cloning and mapping of EcoRI, HindIII, and PstI fragments of bovine herpesvirus 4 (DN-599) genome.

Authors:  V L van Santen; L Y Chang
Journal:  Intervirology       Date:  1992       Impact factor: 1.763

9.  The immediate-early gene product encoded by open reading frame 57 of herpesvirus saimiri modulates gene expression at a posttranscriptional level.

Authors:  A Whitehouse; M Cooper; D M Meredith
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

10.  Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo.

Authors:  J M Lubinski; L Wang; A M Soulika; R Burger; R A Wetsel; H Colten; G H Cohen; R J Eisenberg; J D Lambris; H M Friedman
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

View more
  23 in total

1.  The Herpesviridae Conserved Multifunctional Infected-Cell Protein 27 (ICP27) Is Important but Not Required for Replication and Oncogenicity of Marek's Disease Alphaherpesvirus.

Authors:  Nagendraprabhu Ponnuraj; Yung-Tien Tien; Widaliz Vega-Rodriguez; Andrea Krieter; Keith W Jarosinski
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

2.  Marek's disease virus expresses multiple UL44 (gC) variants through mRNA splicing that are all required for efficient horizontal transmission.

Authors:  Keith W Jarosinski; Nikolaus Osterrieder
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

3.  Herpes simplex virus-1 infection causes the secretion of a type I interferon-antagonizing protein and inhibits signaling at or before Jak-1 activation.

Authors:  Karen E Johnson; David M Knipe
Journal:  Virology       Date:  2009-10-31       Impact factor: 3.616

4.  Herpes simplex virus ICP27 regulates alternative pre-mRNA polyadenylation and splicing in a sequence-dependent manner.

Authors:  Shuang Tang; Amita Patel; Philip R Krause
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-10       Impact factor: 11.205

Review 5.  Intron retention in viruses and cellular genes: Detention, border controls and passports.

Authors:  David Rekosh; Marie-Louise Hammarskjold
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-03-06       Impact factor: 9.957

6.  Comprehensive Mutagenesis of Herpes Simplex Virus 1 Genome Identifies UL42 as an Inhibitor of Type I Interferon Induction.

Authors:  Maxime Chapon; Kislay Parvatiyar; Saba Roghiyh Aliyari; Jeffrey S Zhao; Genhong Cheng
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

7.  Herpes simplex virus 2 expresses a novel form of ICP34.5, a major viral neurovirulence factor, through regulated alternative splicing.

Authors:  Shuang Tang; Nini Guo; Amita Patel; Philip R Krause
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

8.  Up to four distinct polypeptides are produced from the γ34.5 open reading frame of herpes simplex virus 2.

Authors:  Maria Korom; Katie L Davis; Lynda A Morrison
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

9.  The Splicing History of an mRNA Affects Its Level of Translation and Sensitivity to Cleavage by the Virion Host Shutoff Endonuclease during Herpes Simplex Virus Infections.

Authors:  Jouliana Sadek; G Sullivan Read
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

10.  Herpesvirus protein ICP27 switches PML isoform by altering mRNA splicing.

Authors:  Takayuki Nojima; Takako Oshiro-Ideue; Hiroto Nakanoya; Hidenobu Kawamura; Tomomi Morimoto; Yasushi Kawaguchi; Naoyuki Kataoka; Masatoshi Hagiwara
Journal:  Nucleic Acids Res       Date:  2009-09-03       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.